Growing Opportunities in Outsourced Biopharma APIs

[...]the increase in the percentage of outsourced biologies points to the fact that contract manufacturing of biologies today is a strategic, integral part of the industry. Since BioPlan Associates began evaluating outsourced production in 2010, there has been a steady increase. [...]outsourcing has...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutical technology Europe 2023-10, Vol.35 (10), p.32-33
Main Author: Nissinoff, Doug
Format: Article
Language:English
Subjects:
Cell culture
Fermentation
Manufacturing
Outsourcing
Trends
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[...]the increase in the percentage of outsourced biologies points to the fact that contract manufacturing of biologies today is a strategic, integral part of the industry. Since BioPlan Associates began evaluating outsourced production in 2010, there has been a steady increase. [...]outsourcing has become an attractive option for its cost-effectiveness, allowing companies to mitigate risks and operational expenses. [...]there is a strategic move toward focusing on core activities such as R&D, with companies offloading the manufacturing aspect to specialized contract organizations.
ISSN:1753-7967